Evonik is one of the world's leading specialty chemicals companies. Profitable growth and a sustained increase in the value of the company form the heart of their strategy, which is supported by their owners, RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01 percent).
Their specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalisation—and their goal is to enter attractive future-oriented markets.
In 2011 Evonik"s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
Their specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalisation—and their goal is to enter attractive future-oriented markets.
In 2011 Evonik"s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
Visit the website HERE.
